Biomune Appoints New Board Members

Biomune Pty Ltd has announced the appointment of two new directors. Rodney Unsworth joins the company as Non-Executive Chairman and David Cooper has joined as Executive Director and Chief Financial Officer.

“Rodney and David bring a wealth of experience and expertise that will well position Biomune as we move towards commercialising our products” explained Managing Director, Ian Jackson. Rodney Unsworth has over 40 years global pharmaceutical experience in executive roles, both in Australia and Asia. David Cooper has over 20 years’ experience in public accounting and financial advisory services in the US and Australia.

“What’s really exciting is that they both passionately believe in the products we’ve developed, as well as the Australian and global market opportunities they will address. I’m really looking forward to closely working with them both,” he said.

About Biomune

Biomune has pioneered the development of evidence based immunobiotic products that optimises the gut-lung physiology to naturally promote wellness of the respiratory system and protect it against virus and bacterial pathogens.